Table 1.
Characteristic | Frequency (%) |
Donor-recipient sex match-no. (%) | |
Male-male | 85(41.3) |
Male-female | 54(26.2) |
Female-male | 36(17.5) |
Female-female | 31(15) |
Age Mean(SD) | 22.5(8.73) |
Age(years), Median(range) | 20(2–51) |
Donor age, Median(range) | 21(2–55) |
Age group – no. (%) | |
< 15 yr | 37(18) |
16–20 yr | 72(35) |
21–30 yr | 64(31.1) |
31–40 yr | 22(10.7) |
> 40 yr | 11(5.3) |
Outcomes-no. (%) | |
Death | 76(39.9) |
Relapse | 59(28.6) |
aGVHD | 136(77.7) |
cGVHD | 34(24.1) |
Platelet recovery | 141(75.0) |
Neutrophil recovery | 167(85.6) |
Time of aGVHD-day | |
Mean(SD) | 13.3(16.5) |
Median | 9 |
Range | 3–90 |
Time of cGVHD-day | |
Mean(SD) | 160.26(73.4) |
Median | 140 |
Range | 91–327 |
Time of relapse-day | |
Mean(SD) | 580(555) |
Median | 412 |
Range | 10–2661 |
Time of platelet recovery-day | |
Mean(SD) | 20.8(19.2) |
Median | 17 |
Range | 1–165 |
Time of neutrophil recovery-day | |
Mean(SD) | 13.46(12.8) |
Median | 11 |
Range | 1–160 |
Follow up-month | |
Median | 16 |
range | 3–89 |
aGVHD, acute graft-versus-host disease; cGVHD, chronic graft-versus-host disease